-

Lost Money in Cronos Group, Inc.?

Gibbs Law Group Investigates Potential Securities Law Violations

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Cronos Group Inc. dropped 15% on November 9, 2021, after the company announced in an SEC filing that it would be required to restate its financial statements for the three and six months ended June 30, 2021, and that it should have taken an impairment charge of at least $220 million for that same period. Cronos’ price dropped another 5% on November 19, 2021 after announcing it had received a non-compliance delinquency letter from Nasdaq due to its ill-timed Form 10-Q filing. As of February 14, 2022, Cronos has still not filed their restatement. Gibbs Law Group is looking into a potential Cronos Securities Class Action Lawsuit on behalf of shareholders who lost money in Cronos Group Inc. (NASDAQ: CRON).

To speak with an attorney regarding this class action lawsuit investigation, click here or call (888) 410-2925.

On Tuesday, November 9, 2021, shares of the cannabis company Cronos Group crashed after announcing that it would not file its quarterly report for the period ended Sept. 30, 2021, in a timely manner. That same day, Cronos disclosed in an SEC filing that it would be required to restate its unaudited interim financial statements for the three and six months ended June 30, 2021, previously filed in a Form 10-Q.

In the 8-K filing, Cronos further admitted that it “should have recorded an impairment charge of not less than $220 million on goodwill and indefinite-lived intangible assets in its U.S. reporting unit” for the three and six months ended June 30, 2021. According to the filing, Cronos concluded that the financial statements for this period “should no longer be relied on.”

Following this news, Cronos’ stock price steeply dropped more than 15% in intraday trading on November 9, 2021, causing significant harm to investors.

What Should Cronos Investors Do?

If you invested in Cronos, visit our website or contact our securities team directly at (888) 410-2925 to discuss how you may be able to recover your losses. Our investigation concerns whether Cronos Group has violated federal securities laws by providing false or misleading statements to investors.

About Gibbs Law Group

Gibbs Law Group represents investors throughout the country in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

EILEEN EPSTEIN
510.350.9728
EJE@CLASSLAWGROUP.COM

Gibbs Law Group

NASDAQ:CRON

Release Summary
Gibbs Law Group is investigating potential legal claims on behalf of CRON investors.
Release Versions
$Cashtags
Hashtags

Contacts

EILEEN EPSTEIN
510.350.9728
EJE@CLASSLAWGROUP.COM

More News From Gibbs Law Group

Class Action Lawsuit Filed Against Richtech Robotics; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura announces a class action lawsuit has been filed on behalf of Richtech Robotics Inc. (RR) investors....

Richtech Robotics Inc. Under Investigation After 20% Stock Drop

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Richtech Robotics Inc. (“Richtech Robotics”) fell over 20% in intraday trading on January 29, 2026, after Hunterbrook Media published a report accusing the company of misrepresenting its “collaboration” with Microsoft and missing its 10-K extended filing deadline. Gibbs Mura is investigating a potential Richtech Robotics Inc. (NASDAQ: RR) Securities Class Action Lawsuit concerning whether Richtech Robotics has violated federal securities laws by provi...

Kaiser Agrees To Historic $556 Million To Settle Whistleblower Lawsuit Over Alleged Medicare Fraud

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is pleased to announce that Kaiser Permanente has agreed to pay $556 million to resolve allegations of Medicare Advantage risk-adjustment fraud. This is believed to be the largest Medicare Part C qui tam settlement ever reached, and is one of the largest whistleblower settlements brought under the False Claims Act settlements in recent years. Our firm’s client, Ronda Osinek was the first whistleblower to file a complaint against Kaiser in the long-ru...
Back to Newsroom